CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $120,165,474
- in 11 filings, $3.7M under 10b5-1 plans
Net −$120,165,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-27 | Catinazzo Thomas Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +78,540 | 78,540 | ||
| 2022-01-27 | Bergstrom Donald A President, R&D | Grant or award | +64,950 | 109,920 | ||
| 2022-01-27 | Bergstrom Donald A President, R&D | Grant or award · Stock Option (Right to Buy) | +129,900 | 129,900 | ||
| 2022-01-27 | Adams Brian Chief Legal Officer | Grant or award | +39,270 | 64,917 | ||
| 2022-01-27 | Adams Brian Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +78,540 | 78,540 | ||
| 2021-12-31 | Adams Brian General Counsel | Grant or award | +658 | $26.10 | $17K | 25,647 |
| 2021-12-31 | Patel Sanjiv President and CEO | Grant or award | +658 | $26.10 | $17K | 253,740 |
| 2021-12-27 | Porter Andy See Remarks | Sale | −260 | $33.10 | $9K | 23,147 |
| 2021-12-27 | Catinazzo Thomas Senior Vice President, Finance | Sale | −295 | $33.10 | $10K | 14,989 |
| 2021-12-27 | Bergstrom Donald A See Remarks | Sale | −649 | $33.10 | $21K | 44,970 |
| 2021-12-27 | Adams Brian General Counsel | Sale | −295 | $33.10 | $10K | 24,989 |
| 2021-11-15 | Catinazzo Thomas Senior Vice President, Finance | Option exercise | +22,500 | $4.12 | $93K | 37,784 |
| 2021-11-15 | Catinazzo Thomas Senior Vice President, Finance | Sale | −22,500 | $35.40 | $797K | 15,284 |
| 2021-11-15 | Catinazzo Thomas Senior Vice President, Finance | Option exercise · Stock Option (Right to Buy) | −22,500 | 39,543 | ||
| 2021-11-15 | Adams Brian General Counsel | Option exercise | +6,500 | $4.12 | $27K | 31,784 |
| 2021-11-15 | Adams Brian General Counsel | Sale | −6,500 | $35.42 | $230K | 25,284 |
| 2021-11-15 | Adams Brian General Counsel | Option exercise · Stock Option (Right to Buy) | −6,500 | 140,786 | ||
| 2021-10-15 | Bergstrom Donald A See Remarks | Sale | −30,000 | $34.15 | $1.0M | 45,619 |
| 2021-09-27 | Catinazzo Thomas Senior Vice President, Finance | Sale | −293 | $36.87 | $11K | 15,284 |
| 2021-09-27 | Bergstrom Donald A See Remarks | Sale | −646 | $36.87 | $24K | 75,619 |
Page 22 of 27 · 534 trades